Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

1,2100 0,0000 (0,00%) In data: 02:22PM EDT. Mercato aperto.

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

Settore/i: Healthcare
Settore: Medical Distribution
Impiegati a tempo pieno: 48.164

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Qiuhua Yang	Executive Chairman	N/D	N/D	1972
Mr. Bo Shen	President, CFO, Head of the Accounting Department & Executive Director	779,06k	N/D	1973
Mr. Yongzhong Li	VP & Executive Director	832,8k	N/D	1970
Mr. Ming Dong	Executive Director	N/D	N/D	1976
Mr. Tao Zhong	VP, Board Secretary & Joint Company Secretary	N/D	N/D	1972
Mr. Dongming Li	Vice President	N/D	N/D	1969
Ms. Shuai Shao	Vice President	N/D	N/D	1988
Dr. Shunjiang Yu	Chief Medical Officer	N/D	N/D	N/D
Ms. Pui Kiu Wong	Joint Company Secretary	N/D	N/D	N/D
Ying Ke	Director & General Manager of R&D Management Center	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Governance aziendale

L'ISS Governance QualityScore di Shanghai Pharmaceuticals Holding Co., Ltd al 1 maggio 2024 è 8. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 10; diritti degli azionisti: 9; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.